Stay updated on Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Sign up to get notified when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.

Latest updates to the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now consolidates site information under a general Locations heading, listing Arkansas, California, Florida, Massachusetts, South Carolina, and Virginia. Per-state location sections were removed, and the page revision updated to v3.3.3.SummaryDifference0.7%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedRemoved the temporary notice about government funding and NIH operating status from the page.SummaryDifference0.3%

- Check61 days agoChange DetectedThese changes are minor UI updates and metadata changes that do not modify the study's core details. There were no changes to eligibility criteria, interventions, primary outcomes, or location lists.SummaryDifference0.4%

- Check82 days agoChange DetectedUpdated operating status notice and new version (v3.2.0) replacing the old v3.1.0. The page now informs users about potential delays and non-processing of transactions due to funding lapses, and points to official sites for status updates.SummaryDifference4%

- Check89 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.